UnknownNot Applicable

Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

South Korea2,000 participantsStarted 2016-04-01

Plain-language summary

Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. 19 years old or older
✓. Clinical evidence of coronary artery disease including asymptomatic ischemia, stable angina pectoris, acute coronary syndrome (unstable angina, non-ST segment elevation myocardial infarction, ST segment elevation myocardial infarction).
✓. Vessel diameter 2.25 \~ 3.5mm, stenosis more than 50% (However, the number of blood vessels, the number of lesions, and the lesion length are not limited)
✓. Voluntary written consent to participate in the trial

✕. Within 24 hours before percutaneous coronary intervention, hemodynamic instability or cardiogenic shock
✕. Life expectancy within 2 years

The incidence of 1-year target lesion failure

Timeframe: 1-year

NCT IDNCT02986295

SponsorHyeon-Cheol Gwon

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-31

Hyeon Cheol Gwon